STAT+ includes exclusive reporting about the pharmaceutical and biotech industries, the health tech industry, science, and coverage at the intersection of health and policy. This resource also tracks advancements in CRISPR, breakthrough medical devices, and drug pricing policies. STAT+ is a premium subscription service of Stat News. 

MSK users can create an account onsite/remotely/on VPN/off VPN to view articles on STAT+. Access just requires that a user have a valid @mskcc.org email address. To sign up for an account, visit www.statnews.com/subscribe, and enter an MSK email address and create a password.